Literature DB >> 10903865

Modeling of the TCR-MHC-peptide complex.

O Michielin1, I Luescher, M Karplus.   

Abstract

The methodology for generating a homology model of the T1 TCR-PbCS-K(d) class I major histocompatibility complex (MHC) class I complex is presented. The resulting model provides a qualitative explanation of the effect of over 50 different mutations in the region of the complementarity determining region (CDR) loops of the T cell receptor (TCR), the peptide and the MHC's alpha(1)/alpha(2) helices. The peptide is modified by an azido benzoic acid photoreactive group, which is part of the epitope recognized by the TCR. The construction of the model makes use of closely related homologs (the A6 TCR-Tax-HLA A2 complex, the 2C TCR, the 14.3.d TCR Vbeta chain, the 1934.4 TCR Valpha chain, and the H-2 K(b)-ovalbumine peptide), ab initio sampling of CDR loops conformations and experimental data to select from the set of possibilities. The model shows a complex arrangement of the CDR3alpha, CDR1beta, CDR2beta and CDR3beta loops that leads to the highly specific recognition of the photoreactive group. The protocol can be applied systematically to a series of related sequences, permitting the analysis at the structural level of the large TCR repertoire specific for a given peptide-MHC complex. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903865     DOI: 10.1006/jmbi.2000.3788

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Modeling the structure of bound peptide ligands to major histocompatibility complex.

Authors:  Joo Chuan Tong; Tin Wee Tan; Shoba Ranganathan
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

2.  T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.

Authors:  Matthew N Davies; Darren R Flower; Kanchan Phadwal; Isabel K Macdonald; Peter V Coveney; Shunzhou Wan
Journal:  Immunome Res       Date:  2010-11-03

3.  Evolution of the variable gene segments and recombination signal sequences of the human T-cell receptor alpha/delta locus.

Authors:  Marsha R Haynes; Gillian E Wu
Journal:  Immunogenetics       Date:  2004-09-18       Impact factor: 2.846

4.  A modeled structure for amidase-03 from Bacillus anthracis.

Authors:  Ravi Datta Sharma; Nabajyoti Goswami; Andrew M Lynn; Pradeep Kumar Sharma; Safdar Jawaid
Journal:  Bioinformation       Date:  2009-12-31

5.  TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires.

Authors:  Antoine Leimgruber; Mathias Ferber; Melita Irving; Hamid Hussain-Kahn; Sébastien Wieckowski; Laurent Derré; Nathalie Rufer; Vincent Zoete; Olivier Michielin
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

6.  Modeling the bound conformation of Pemphigus vulgaris-associated peptides to MHC Class II DR and DQ alleles.

Authors:  Joo Chuan Tong; Jeff Bramson; Darja Kanduc; Selwyn Chow; Animesh A Sinha; Shoba Ranganathan
Journal:  Immunome Res       Date:  2006-01-21

7.  Quantitative Analysis of the Association Angle between T-cell Receptor Vα/Vβ Domains Reveals Important Features for Epitope Recognition.

Authors:  Thomas Hoffmann; Angela M Krackhardt; Iris Antes
Journal:  PLoS Comput Biol       Date:  2015-07-17       Impact factor: 4.475

8.  T-cell receptors binding orientation over peptide/MHC class I is driven by long-range interactions.

Authors:  Mathias Ferber; Vincent Zoete; Olivier Michielin
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 9.  Peptide Vaccine: Progress and Challenges.

Authors:  Weidang Li; Medha D Joshi; Smita Singhania; Kyle H Ramsey; Ashlesh K Murthy
Journal:  Vaccines (Basel)       Date:  2014-07-02

Review 10.  Structure-Based, Rational Design of T Cell Receptors.

Authors:  V Zoete; M Irving; M Ferber; M A Cuendet; O Michielin
Journal:  Front Immunol       Date:  2013-09-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.